Teddy European Network of Excellence for Paediatric Research was funded in 2005 with the aim to favor the integration of the paediatric pharmacological research activities and contribute to the promotion of safe and efficacious medicines for children.
TEDDY is a Network of Excellence (NoE), strongly proactive in the promotion and implementation of adequate health policies and a social awareness on the importance of the paediatric medicines across Europe.
Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from more than 20 countries aimed at facilitating the performance of good quality paediatric studies and research.
TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.
Moreover, TEDDY is member of Enpr-EMA Coordinating Group.
Any research centres and groups willing to be engaged in the development of clinical research can join the TEDDY Network. Find out more.
Covid-19
Are you a patient or a caregiver? Or do you want just to have clearer information about Covid-19?
Have a look at these Covid-19 Informative Fact Sheets.
Latest News
SAVE THE DATE. 2-4 November, 2020. Clinical Trials Europe 2020
The Clinical Trials Europe is the Europe's largest event dedicated to streamlining clinical trials and improving patient outcomes. The 2020 Edition will take place virtually on 2-4 November due to covid-19 pandemic. The
SAVE THE DATE: 30-11-2020. Workshop on support for orphan medicines development
The Committee for Orphan Medicinal Product (COMP) of the European Medicines Agency (EMA) will organise a Workshop on support for orphan medicines development on 30 November 2020. The virtual event aims to encourage
